SG11201404959TA - Sirtuin inducer, tissue repairing agent, hepatocyte growth factor inducer, tissue homeostasis maintenance agent, and tlr4 agonist, having hyaluronic acid fragment as active agent - Google Patents

Sirtuin inducer, tissue repairing agent, hepatocyte growth factor inducer, tissue homeostasis maintenance agent, and tlr4 agonist, having hyaluronic acid fragment as active agent

Info

Publication number
SG11201404959TA
SG11201404959TA SG11201404959TA SG11201404959TA SG11201404959TA SG 11201404959T A SG11201404959T A SG 11201404959TA SG 11201404959T A SG11201404959T A SG 11201404959TA SG 11201404959T A SG11201404959T A SG 11201404959TA SG 11201404959T A SG11201404959T A SG 11201404959TA
Authority
SG
Singapore
Prior art keywords
agent
inducer
tissue
growth factor
hyaluronic acid
Prior art date
Application number
SG11201404959TA
Other languages
English (en)
Inventor
Akira Asari
Jeroen CODEE
Original Assignee
Hyaluronan Res Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyaluronan Res Inst Inc filed Critical Hyaluronan Res Inst Inc
Publication of SG11201404959TA publication Critical patent/SG11201404959TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Hospice & Palliative Care (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
SG11201404959TA 2012-02-22 2013-02-21 Sirtuin inducer, tissue repairing agent, hepatocyte growth factor inducer, tissue homeostasis maintenance agent, and tlr4 agonist, having hyaluronic acid fragment as active agent SG11201404959TA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2012035745 2012-02-22
JP2012035743 2012-02-22
JP2012208055 2012-09-21
PCT/JP2013/054330 WO2013125634A1 (ja) 2012-02-22 2013-02-21 ヒアルロン酸フラグメントを有効成分とするサーチュイン誘導剤、組織修復剤、肝細胞増殖因子誘導剤、組織恒常性維持剤、及びｔｌｒ４作用剤

Publications (1)

Publication Number Publication Date
SG11201404959TA true SG11201404959TA (en) 2014-11-27

Family

ID=49005811

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201404959TA SG11201404959TA (en) 2012-02-22 2013-02-21 Sirtuin inducer, tissue repairing agent, hepatocyte growth factor inducer, tissue homeostasis maintenance agent, and tlr4 agonist, having hyaluronic acid fragment as active agent

Country Status (6)

Country Link
US (1) US20150018305A1 (ja)
EP (2) EP2818172A4 (ja)
JP (3) JPWO2013125634A1 (ja)
CA (1) CA2871993A1 (ja)
SG (1) SG11201404959TA (ja)
WO (1) WO2013125634A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3019177T3 (pl) 2013-07-10 2021-04-19 Matrix Biology Institute Kompozycje hialuronianu o dużej sprężystości i ich zastosowania
JP2015096493A (ja) * 2013-10-08 2015-05-21 日本新薬株式会社 アクアポリン機能亢進剤
CN108135926A (zh) 2015-09-24 2018-06-08 基质生物研究所 高弹性透明质酸组合物及其使用方法
US10973858B2 (en) 2016-02-12 2021-04-13 Laimu Corporation Nerve growth promoter and method for producing same, internal preparation, medium additive, cell dilution additive, medium, cell dilution, antioxidant and method for producing same, external preparation, and wound treatment agent and method for producing same
JP6230638B2 (ja) * 2016-02-12 2017-11-15 株式会社らいむ 神経伸長促進剤、内服剤、培地用添加剤、細胞希釈液用添加剤、培地および細胞希釈液
KR101976480B1 (ko) * 2017-07-14 2019-05-10 서울대학교 산학협력단 신규 알츠하이머병 치료용 약학적 조성물
US11439659B2 (en) * 2018-12-03 2022-09-13 The Regents Of The University Of California Methods and compositions to prevent and treat inflammation and allergic reactions
JP7104942B2 (ja) * 2020-08-28 2022-07-22 日本コルマー株式会社 ゲル状組成物
FR3118415A1 (fr) * 2020-12-30 2022-07-01 Universite De Picardie Jules Verne Composition pharmaceutique contenant en tant qu’ingrédient actif au moins un composé de type disaccharide capable d’augmenter la production de calcium des cellules pré-ostéoblastiques –kit et composés associés

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5213733A (en) 1975-07-24 1977-02-02 Tech Res & Dev Inst Of Japan Def Agency Pattern characteristic sampling method
GB8713747D0 (en) * 1987-06-12 1987-07-15 Unilever Plc Skin treatment composition
JPH05213733A (ja) 1992-02-05 1993-08-24 Sansho Seiyaku Co Ltd 皮膚化粧料
JP4195107B2 (ja) * 1996-02-16 2008-12-10 生化学工業株式会社 ストレス蛋白質発現増強剤
GB2379244B (en) * 2000-07-07 2004-05-05 Southco Electrically operated ratcheting pawl latch
CA2414211C (en) * 2000-07-07 2011-08-02 Seikagaku Corporation Hyaluronic acid oligosaccharide fractions and drugs containing the same
WO2002074318A1 (fr) * 2001-03-15 2002-09-26 Seikagaku Corporation Agents de regulation d'expression d'il-12
WO2002083185A1 (fr) * 2001-04-06 2002-10-24 Chugai Seiyaku Kabushiki Kaisha Procede de transfert genique via le systeme vasculaire ou l'uretere
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
US20070032451A1 (en) * 2005-02-28 2007-02-08 Kipling Thacker Blood soluble drag reducing hyaluronic acid
JP2007084509A (ja) * 2005-09-26 2007-04-05 Toshitsu Kagaku Kenkyusho:Kk 細胞賦活剤
JP2006327959A (ja) * 2005-05-24 2006-12-07 Toshitsu Kagaku Kenkyusho:Kk 内分泌性疾患及び代謝性疾患の治療剤
JP4022659B2 (ja) * 2005-05-24 2007-12-19 株式会社 糖質科学研究所 自己免疫疾患、炎症及び神経疾患の治療剤及び予防剤
JP2007153761A (ja) * 2005-12-01 2007-06-21 Toshitsu Kagaku Kenkyusho:Kk シナプス伝達促進剤及びシナプス保護剤
JP4041856B2 (ja) * 2005-06-02 2008-02-06 株式会社 糖質科学研究所 変形性関節症の治療剤
CA2560844C (en) * 2005-09-26 2011-05-17 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
JP2007126453A (ja) * 2005-10-07 2007-05-24 Toshitsu Kagaku Kenkyusho:Kk ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤
JP2007153766A (ja) * 2005-12-01 2007-06-21 Toshitsu Kagaku Kenkyusho:Kk Ｍａｐキナーゼキナーゼキナーゼ遺伝子の発現増強剤
US8153614B2 (en) * 2006-12-05 2012-04-10 Glycoscience Laboratories, Inc. Treatment of osteoarthritis
JP2008201749A (ja) * 2007-02-21 2008-09-04 Okayama Univ 肝細胞増殖因子産生誘導剤及びその医薬品組成物
JP2008266171A (ja) * 2007-04-18 2008-11-06 Q P Corp 自己免疫疾患緩和剤ならびにこれを含有する医薬品および食品
JP4754532B2 (ja) * 2007-07-09 2011-08-24 生化学工業株式会社 ヒアルロン酸オリゴ糖を有効成分とする治療剤
JP2009292767A (ja) * 2008-06-05 2009-12-17 Toshitsu Kagaku Kenkyusho:Kk 神経細胞分化誘導剤
JP2010059084A (ja) * 2008-09-03 2010-03-18 Q P Corp 機能性食品及び医薬
JP2013125634A (ja) * 2011-12-14 2013-06-24 Toshiba Lighting & Technology Corp 調光器及び調光システム

Also Published As

Publication number Publication date
EP2818172A4 (en) 2016-02-17
EP3100736A1 (en) 2016-12-07
US20150018305A1 (en) 2015-01-15
JP2017036326A (ja) 2017-02-16
JPWO2013125634A1 (ja) 2015-07-30
JP2019116511A (ja) 2019-07-18
JP6772415B2 (ja) 2020-10-21
EP2818172A1 (en) 2014-12-31
CA2871993A1 (en) 2013-08-29
WO2013125634A1 (ja) 2013-08-29

Similar Documents

Publication Publication Date Title
SG11201404959TA (en) Sirtuin inducer, tissue repairing agent, hepatocyte growth factor inducer, tissue homeostasis maintenance agent, and tlr4 agonist, having hyaluronic acid fragment as active agent
FI20185380A (fi) Laitteisto ja menetelmä laiteliipaisuviestien tehokkaaseen lähettämiseen
ZA201309101B (en) Surgical anchor delivery system
IL234948A0 (en) Equipment for tissue expansion systems and methods
ZA201308417B (en) Tissue healing
EP2739974A4 (en) METHOD AND COMPOSITIONS FOR HEART ERROR MONITORING
EP2766390A4 (en) COMPOSITIONS AND METHODS FOR TREATING HEART ERRORS
HUE038664T2 (hu) Hialuronsav C6-C18-acilezett származéka, eljárás annak elõállítására, erre épülõ nanomicelláris kompozíció, eljárás annak elõállítására és eljárás stabilizált nanomicelláris kompozíció elõállítására, valamint annak alkalmazása
PL2882779T3 (pl) Pochodna kwasu hialuronowego, sposób jej wytwarzania, sposób jej modyfikacji i jej zastosowanie
PL2672966T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
EP2830637A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING DISEASES RELATED TO OXIDATIVE STRESS
EP2776115A4 (en) MEDICAL PLASTER AND INJECTOR SYSTEM
PL2729151T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
HRP20190573T1 (hr) Piranokromenil fenol derivat, i farmaceutska kompozicija za liječenje metaboličkog sindroma ili inflamatorne bolesti
EP2593109A4 (en) METHOD AND FORMULATIONS FOR THE TREATMENT OF SIALIC ACID DEFICIENCIES
ZA201306388B (en) Methods and compositions for treating,reducing,or preventing deterioration of the visual system of animals
BR112013024079A2 (pt) métodos e composições para aumento da produtividade das plantas
EP2937088A4 (en) COMPOSITION HAVING TISSUE REPAIR ACTIVITY AND USE THEREOF
EP2688402A4 (en) METHODS FOR THE TREATMENT OR PREVENTION OF UROLOGIC INFLAMMATION
IL233225A0 (en) Methods and formulations for the treatment of sialic acid deficiencies
EP2690559A4 (en) SYSTEM, METHOD FOR OPERATIONS ADMINISTRATION AND PROGRAM
EP2663343A4 (en) DEVICES AND METHODS FOR TISSUE ENGINEERING
BR112013028989A2 (pt) método para administrar a infraestrutura de um serviço de rede de distribuição de conteúdo em uma rede de isp, e infraestrutura de um serviço de rede de distribuição de conteúdo em uma rede de isp
EP2902413A4 (en) POLYPEPTIDE, FRUIT COMPOSITION, COMPOSITION FOR CARTILAGE RANGE TESTING, COMPOSITION FOR CORTIC CELL CULTURE AND COMPOSITION FOR PROMOTING GLYCOSAMINOGLYCAN PRODUCTION
EP2872166A4 (en) COMPOSITIONS AND METHODS OF DETECTING, TREATING AND PREVENTING ILLNESSES AND DISORDERS